Stay updated on Obeticholic Acid in NASH Clinical Trial
Sign up to get notified when there's something new on the Obeticholic Acid in NASH Clinical Trial page.

Latest updates to the Obeticholic Acid in NASH Clinical Trial page
- Check3 days agoChange DetectedDeleted the topic tag 'Non-alcoholic fatty liver disease' and the related topic 'MedlinePlus Genetics' from the study page metadata.SummaryDifference0.0%

- Check11 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. The previous revision tag was removed and the new revision tag added.SummaryDifference0.0%

- Check39 days agoChange DetectedMinor metadata updates: 'Non-alcoholic fatty liver disease' and 'MedlinePlus Genetics' were added as related topics, and the revision version updated from 3.4.0 to 3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision: v3.3.4 added and Revision: v3.3.3 removed from the Study Documents section. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedLocations section updated to include a comprehensive list of site locations by state and country, expanding the geographic reach of the trial. The HHS Vulnerability Disclosure entry and several location groupings were removed.SummaryDifference1%

Stay in the know with updates to Obeticholic Acid in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Obeticholic Acid in NASH Clinical Trial page.